|
Volumn 22, Issue 1, 2011, Pages 75-78
|
Efficacy of low dose spironolactone in chronic kidney disease with resistant hypertension.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
SPIRONOLACTONE;
ADULT;
ARTICLE;
BLOOD PRESSURE;
CHEMICALLY INDUCED DISORDER;
CHRONIC DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG COMBINATION;
DRUG EFFECT;
DRUG RESISTANCE;
FEMALE;
GLOMERULUS FILTRATION RATE;
HOSPITALIZATION;
HUMAN;
HYPERKALEMIA;
HYPERTENSION;
IRAN;
KIDNEY DISEASE;
MALE;
MIDDLE AGED;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
TIME;
TREATMENT OUTCOME;
ADULT;
ALDOSTERONE ANTAGONISTS;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CHRONIC DISEASE;
DOUBLE-BLIND METHOD;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
FEMALE;
GLOMERULAR FILTRATION RATE;
HUMANS;
HYPERKALEMIA;
HYPERTENSION;
IRAN;
KIDNEY DISEASES;
MALE;
MIDDLE AGED;
SEVERITY OF ILLNESS INDEX;
SPIRONOLACTONE;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 79952220553
PISSN: 13192442
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (46)
|
References (0)
|